Company Filing History:
Years Active: 2010
Title: Jussi Tomperi: Innovator in Somatostatin Receptor Research
Introduction
Jussi Tomperi is a notable inventor based in Turku, Finland. He has made significant contributions to the field of pharmacology, particularly in the development of selective agonists and antagonists for somatostatin receptors. His work has implications for the treatment and diagnosis of various diseases.
Latest Patents
Jussi Tomperi holds a patent for "Somatostatin receptor 1 and/or 4 selective agonists and antagonists." This invention relates to (hetero)arylsulfonylamino based peptidomimetics of a specific formula. The compounds possess high affinity and selectivity for the somatostatin receptor subtypes SSTR1 and/or SSTR4. They can be utilized for the treatment or diagnosis of diseases where interaction with these receptors is beneficial.
Career Highlights
Throughout his career, Jussi Tomperi has worked with various companies, including Siegfried Wurster and Wurster, Siegfried. His experience in these organizations has contributed to his expertise in the field of pharmaceutical innovations.
Collaborations
Jussi has collaborated with notable colleagues such as Paivi Hautamaki and Harri Salo. These partnerships have likely enhanced his research and development efforts in the pharmaceutical industry.
Conclusion
Jussi Tomperi's work in somatostatin receptor research exemplifies the impact of innovative thinking in medicine. His contributions continue to influence the development of new therapeutic options.